C. Avancès

1.3k total citations
46 papers, 1.0k citations indexed

About

C. Avancès is a scholar working on Surgery, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C. Avancès has authored 46 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 19 papers in Rheumatology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C. Avancès's work include Urologic and reproductive health conditions (17 papers), Genital Health and Disease (10 papers) and Prostate Cancer Treatment and Research (10 papers). C. Avancès is often cited by papers focused on Urologic and reproductive health conditions (17 papers), Genital Health and Disease (10 papers) and Prostate Cancer Treatment and Research (10 papers). C. Avancès collaborates with scholars based in France, Algeria and Australia. C. Avancès's co-authors include F. Iborra, Stéphane Culine, Lluís Fajas, Vanessa Fritz, Corinne Henriquet, Nicolas Mottet, Virginie Georget, Béatrice Térouanne, Francesco Orio and P. Costa and has published in prestigious journals such as PLoS ONE, The Journal of Urology and Carcinogenesis.

In The Last Decade

C. Avancès

44 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Avancès France 14 449 407 305 179 134 46 1.0k
Gloria Ravegnini Italy 22 427 1.0× 269 0.7× 333 1.1× 188 1.1× 194 1.4× 87 1.4k
Hiroshi Hano Japan 16 362 0.8× 164 0.4× 384 1.3× 162 0.9× 119 0.9× 61 1.1k
Kristy Kutanzi United States 19 713 1.6× 306 0.8× 305 1.0× 75 0.4× 131 1.0× 27 1.4k
Chun‐Nung Huang Taiwan 23 437 1.0× 247 0.6× 371 1.2× 384 2.1× 204 1.5× 82 1.2k
Renato V. La Rocca United States 16 345 0.8× 205 0.5× 362 1.2× 172 1.0× 335 2.5× 24 1.2k
Nicoletta Campanini Italy 22 482 1.1× 280 0.7× 428 1.4× 213 1.2× 848 6.3× 71 1.7k
Jan Novotný Czechia 21 737 1.6× 508 1.2× 77 0.3× 96 0.5× 406 3.0× 61 1.4k
J. Szymańska Poland 10 336 0.7× 206 0.5× 198 0.6× 132 0.7× 130 1.0× 22 880
S. Fleming United Kingdom 22 687 1.5× 166 0.4× 463 1.5× 164 0.9× 107 0.8× 59 1.3k

Countries citing papers authored by C. Avancès

Since Specialization
Citations

This map shows the geographic impact of C. Avancès's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Avancès with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Avancès more than expected).

Fields of papers citing papers by C. Avancès

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Avancès. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Avancès. The network helps show where C. Avancès may publish in the future.

Co-authorship network of co-authors of C. Avancès

This figure shows the co-authorship network connecting the top 25 collaborators of C. Avancès. A scholar is included among the top collaborators of C. Avancès based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Avancès. C. Avancès is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Avancès, C., Philippe Camparo, Xavier Durand, et al.. (2014). Prise en charge des tératomes testiculaires : mise au point par le Comité de cancérologie de l’Association française d’urologie groupe organes génitaux externes (CCAFU-OGE). Progrès en Urologie. 24(16). 1050–1053. 1 indexed citations
2.
Avancès, C., J. Rigaud, Philippe Camparo, et al.. (2013). Contribution 2013 du CCAFU au référentiel INCa : Sarcomes du rétropéritoine. Progrès en Urologie. 23. S161–S166.
3.
Sèbe, Philippe, J. Rigaud, C. Avancès, et al.. (2013). Contribution 2013 du CCAFU au référentiel INCa : Tumeurs malignes de la surrénale. Progrès en Urologie. 23. S167–S174. 5 indexed citations
4.
Durand, Xavier, J. Rigaud, C. Avancès, et al.. (2013). Recommandations en onco-urologie 2013 du CCAFU : Tumeurs germinales du testicule. Progrès en Urologie. 23. S145–S160. 14 indexed citations
6.
Fritz, Vanessa, Zohra Benfodda, Geneviève Rodier, et al.. (2010). Abrogation of De novo Lipogenesis by Stearoyl-CoA Desaturase 1 Inhibition Interferes with Oncogenic Signaling and Blocks Prostate Cancer Progression in Mice. Molecular Cancer Therapeutics. 9(6). 1740–1754. 231 indexed citations
7.
Rigaud, J., C. Avancès, Philippe Camparo, et al.. (2010). Recommandations en Onco-Urologie 2010 : Tumeurs malignes du pénis. Progrès en Urologie. 20. S279–S289. 9 indexed citations
8.
Durand, Xavier, C. Avancès, Aude Fléchon, & Nicolas Mottet. (2010). Récidives tardives des tumeurs germinales du testicule. Progrès en Urologie. 20(6). 416–424. 5 indexed citations
9.
Sèbe, Philippe, J. Rigaud, C. Avancès, et al.. (2010). Tumeurs malignes de la surrénale : Contribution du CCAFU au référentiel INCa. Progrès en Urologie. 20. S310–S316. 3 indexed citations
10.
Avancès, C., J. Rigaud, B. Bui, et al.. (2010). Sarcomes du rétropéritoine : Contribution du CCAFU au référentiel INCa. Progrès en Urologie. 20. S290–S296. 2 indexed citations
12.
Fritz, Vanessa, Corinne Henriquet, Florence Apparailly, et al.. (2009). miR-143 Interferes with ERK5 Signaling, and Abrogates Prostate Cancer Progression in Mice. PLoS ONE. 4(10). e7542–e7542. 164 indexed citations
13.
Avancès, C., et al.. (2007). Prélèvement rénal chez le donneur vivant : morbidité et suivi à long terme. Progrès en Urologie. 17(2). 194–198. 2 indexed citations
14.
Avancès, C., et al.. (2006). Prognostic factors for first recurrence in patients with retroperitoneal sarcoma. Urologic Oncology Seminars and Original Investigations. 24(2). 94–96. 22 indexed citations
15.
Boireau, Stéphanie, Michael Büchert, Michael S. Samuel, et al.. (2006). DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinoma. Carcinogenesis. 28(2). 246–258. 76 indexed citations
16.
Pouessel, Damien, Frédéric Bibeau, C. Avancès, et al.. (2006). Liver metastases in prostate carcinoma: clinical characteristics and outcome. British Journal of Urology. 99(4). 807–811. 55 indexed citations
17.
Avancès, C., et al.. (2002). [Efficacy of suburethral TVT in cases of stress urinary incontinence associated with severe sphincter insufficiency. Report of 22 cases].. PubMed. 12(6). 1251–5. 6 indexed citations
18.
Orio, Francesco, Béatrice Térouanne, Virginie Georget, et al.. (2002). Potential action of IGF-1 and EGF on androgen receptor nuclear transfer and transactivation in normal and cancer human prostate cell lines. Molecular and Cellular Endocrinology. 198(1-2). 105–114. 50 indexed citations
19.
Térouanne, Béatrice, Virginie Georget, Charles Belon, et al.. (2000). A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects. Molecular and Cellular Endocrinology. 160(1-2). 39–49. 113 indexed citations
20.
Sultan, Charles, et al.. (1999). [Androgen-independent prostate carcinoma and androgen-receptor: recent progress in molecular genetics].. PubMed. 86(7-8). 618–21. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026